Kumud Kalia

Kumud Kalia is a declared insider of Guardant Health, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 17 August 2022 to 1 October 2026, the count stands at 119 filings.

In open-market terms, that means 4 purchases worth €194k on one side and 15 sales worth €5.4M on the other. Netting one side against the other leaves €5.2M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 38 share grants and 62 option exercises. So far in 2026, the count stands at 1 purchase and 5 sales.

A typical purchase (the median) is worth €52k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -14.5%. This is a record of the past, not a forecast.

On 2 October 2026 came the latest disclosure, an option exercise in Guardant Health, Inc. The latest purchase dates back some time: it was published 115 days ago, on 30 June 2026. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.